[en] We investigated the prevalence of human papillomavirus (HPV) in a clinical series of 72 patients with head and neck squamous cell carcinoma (HNSCC) using a retrospective and prospective study design. The majority of patients were smokers and/or drinkers and were treated with concomitant chemoradiotherapy (CCR). Furthermore, we assessed the impact of HPV positivity on the response to CCR. Paraffin-embedded samples from HNSCC patients (n=72) were evaluated for the presence of HPV DNA using both GP5+/GP6+ consensus PCR and type-specific E6/E7 PCR to detect HPV types 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 67 and 68. The type-specific E6/E7 PCR demonstrated that 20 out of 69 HNSCC patients (29%) presented with high-risk (HR) HPV types and that 5 of the 69 HNSCC patients (7%) presented with low-risk (LR) HPV types. Using the GP5+/GP6+ PCR, we observed that the rate of response was statistically lower in the HPV+ group (P=0.02). Concerning patient outcomes in terms of recurrence and survival, we observed that the prognosis was poorer for HPV+ patients. We showed for the first time that patients with HPV+ HNSCC present with a worse prognosis after CCR. This observation highlights the need for prospective studies with large numbers of patients and a detailed history of tobacco and alcohol consumption before validating HPV as a marker of prognosis following CCR.
Disciplines :
Oncology
Author, co-author :
Duray, Anaelle
Descamps, Geraldine
Decaestecker, Christine
Sirtaine, Nicolas
Gilles, Andre
Khalife, Mohamad
Chantrain, Gilbert
Depuydt, Christophe E.
Delvenne, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Saussez, Sven
Language :
English
Title :
Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
World Health Organization: International Agency for Research on Cancer. Globocan, 2008. Available from: http://globocan.iarc.fr/.
Grandis JR, Pietenpol JA, Greenberger JS, Pelroy RA and Mohla S: Head and neck cancer: meeting summary and research opportunities. Cancer Res 64: 8126-8129, 2004. (Pubitemid 39446952)
Shah JP and Patel SG: Head and Neck Surgery and Oncology. 3rd edition. Mosby, New York, pp 232-236, 352, 2003.
Forastiere AA and Trotti A: Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer. J Natl Cancer Inst 91: 2065-2066, 1999. (Pubitemid 30019565)
Denis F, Garaud P, Bardet E, et al: Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22: 69-76, 2004. (Pubitemid 41095116)
Stenson KM, Kunnavakkam R, Cohen EE, et al: Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope 120: 93-99, 2010.
Milano MT, Vokes EE, Kao J, et al: Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. Int J Oncol 28: 1141-1151, 2006.
Hu M, Ampil F, Clark C, Sonavane K, Caldito G and Nathan CA: Comorbid predictors of poor response to chemoradiotherapy for laryngeal squamous cell carcinoma. Laryngoscope 122: 565-571, 2012.
Sturgis EM and Cinciripini PM: Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110: 1429-1435, 2007. (Pubitemid 47463055)
Dahlstrand H, Nasman A, Romanitan M, Lindquist D, Ramqvist T and Dalianis T: Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 28: 1133-1138, 2008. (Pubitemid 351578850)
Reimers N, Kasper HU, Weissenborn SJ, et al: Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 120: 1731-1738, 2007. (Pubitemid 46399359)
Kumar B, Cordell KG, Lee JS, et al: Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys 69: 109-111, 2007.
Rischin D, Young RJ, Fisher R, et al: Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 28: 4142-4148, 2010.
Lill C, Kornek G, Bachtiary B, et al: Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced. Wien Klin Wochenschr 123: 215-221, 2011.
Hong AM, Dobbins TA, Lee CS, et al: Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer 103: 1510-1517, 2010.
Sedaghat AR, Zhang Z, Begum S, et al: Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 119: 1542-1549, 2009.
Chung YL, Lee MY, Horng CF, et al: Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone. Head Neck 31: 9-20, 2009.
Nichols AC, Faquin WC, Westra WH, et al: HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 140: 228-234, 2009.
de Jong MC, Pramana J, Knegjens JL, et al: HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors. Radiother Oncol 95: 365-370, 2010.
Fallai C, Perrone F, Licitra L, et al: Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status. Int J Radiat Oncol Biol Phys 75: 1053-1059, 2009.
Pim D, Collins M and Banks L: Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7: 27-32, 1992.
Depuydt CE, Benoy IH, Bailleul EJ, Vandepitte J, Vereecken AJ and Bogers JJ: Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi. Cytopathology 17: 374-381, 2006. (Pubitemid 44808532)
Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ and Bogers JJ: Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 11: 881-891, 2007. (Pubitemid 47313308)
Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P and Depuydt C: Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium. Cancer Epidemiol Biomarkers Prev 18: 321-330, 2009.
Filleul O, Preillon J, Crompot E, Lechien J and Saussez S: Incidence of head and neck cancers in Belgium: comparison with worldwide and French data. Bulletin du Cancer 98: 1173-1183, 2011.
Saussez S: Cancer of the upper aero-digestive tract: elevated incidence in Belgium, new risk factors and therapeutic perspectives. Bull Mem Acad R Med Belg 165: 453-461, 2010.
Duray A, Descamps G, Decaestecker C, et al: Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope 122: 1558-1565, 2012.
Rosenquist K, Wennerberg J, Annertz K, et al: Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors. Acta Otolaryngol 127: 980-987, 2007. (Pubitemid 47345810)
Hansson BG, Rosenquist K, Antonsson A, et al: Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 125: 1337-1344, 2005. (Pubitemid 41722001)
Clayman GL, Stewart MG, Weber RS, el-Naggar AK and Grimm EA: Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch Otolaryngol 120: 743-748, 1994. (Pubitemid 24217588)
Giskes K, Kunst AE, Benach J, et al: Trends in smoking behavior between 1985 and 2000 in nine European countries by education. J Epidemiol Community Health 59: 395-401, 2005. (Pubitemid 40559202)
Stanley MA: Immune responses to human papillomaviruses. Indian J Med Res 130: 266-276, 2009.
Hasan UA, Bates E, Takeshita F, et al: TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol 178: 3186-3197, 2007. (Pubitemid 46333201)
Lepique AP, Daghastanli KR, Cuccovia IM and Villa LL: HPV16 tumor associated macrophages suppress antitumor T cell responses. Clin Cancer Res 15: 4391-4400, 2009.
Stanley MA: Immune responses to human papillomavirus. Vaccine 24: 16-22, 2006.
Tung YC, Lin KH, Chu PY, Hsu CC and Kuo WR: Detection of human papillomavirus and Epstein Barr virus DNA in nasopharyngeal carcinoma by polymerase chain reaction. Kaohsiung J Med Sci 15: 256-262, 1999.
Moscicki AB, Hills N, Shiboski S, et al: Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 285: 2995-3002, 2001. (Pubitemid 32550118)
Kreimer AR, Alberg AJ, Daniel R, et al: Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 189: 686-698, 2004. (Pubitemid 38270923)
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.